News from the FDA/CDC

FDA approves starting dose of roflumilast

Taking a smaller dose of a drug currently used to treat COPD may prevent patients from discontinuing their use of the larger therapeutic dose.

From the Journals

Influenza: All that and MI too

Admissions for myocardial infarction spike after laboratory-confirmed flu infection.

Pearl of the Month

Beware the COPD exacerbation

If a COPD patient has all the classic symptoms of an exacerbation, are there still other diagnoses to consider?